Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Aldeyra Therapeutics Q2 EPS $(0.28) Misses $(0.24) Estimate

Aldeyra Therapeutics (NASDAQ:ALDX) reported quarterly losses of $(0.28) per share which missed the analyst consensus estimate of $(0.24) by 16.67 percent. This is a 12 percent decrease over losses of $(0.25) per share

byBenzinga Newsdesk

August 5, 2021

1 minute read

Aldeyra Therapeutics (NASDAQ:ALDX) reported quarterly losses of $(0.28) per share which missed the analyst consensus estimate of $(0.24) by 16.67 percent. This is a 12 percent decrease over losses of $(0.25) per share from the same period last year.